CXCL8 and ovarian serous adenocarcinoma: In a study in 8 patients aged 68 to 78 years, treated for FIGO IIIC and IV serous ovarian cancer, mean concentration of IL-8 was determined in ascites in comparison with the control group comprising 8 women with benign ovary conditions, age-matched with patients in the study group [25].